Extensions

Analysis of Patent Term and Related Applications for US Patent 12,125,070

Based on an analysis of the provided patent data and public records from the U.S. Patent and Trademark Office (USPTO) as of May 7, 2026, the following details pertain to the term and application history of US Patent 12,125,070.

Patent Term Adjustment (PTA) and Extensions (PTE)

• Patent Term Adjustment (PTA): There is no Patent Term Adjustment indicated for US Patent 12,125,070. PTA is granted to compensate for certain administrative delays by the USPTO during patent prosecution. The absence of PTA suggests the prosecution of application US 18/179,264 was completed within the statutory timeframes.
• Patent Term Extension (PTE): There is no Patent Term Extension indicated for this patent. PTE is typically associated with delays in regulatory review for products like pharmaceuticals and is not applicable to this technology.

Continuity and Related Applications

US Patent 12,125,070 is part of a large family of applications and claims priority to several earlier filings. This indicates a long history of prosecution, with the core invention being refined and pursued through a series of continuation applications.

• Application Number: The application that matured into this patent is US 18/179,264, which was filed on March 6, 2023.
• Continuation History: This application is a continuation of prior applications. The chain of priority, which is critical for determining the patent's expiration date, goes back to earlier filings:
  • It claims priority to U.S. Application No. 12/785,406, filed on May 21, 2010 (now U.S. Patent No. 10,191,972).
  • This, in turn, claims priority to U.S. Application No. 12/433,881, filed on April 30, 2009 (now U.S. Patent No. 8,660,539).
• Divisional Applications: There is no indication of any divisional applications directly from the application leading to the '070 patent.
• Subsequent Applications: The patent data indicates a subsequent application, U.S. Application No. 18/895,184, was filed on September 24, 2024, claiming priority to the '070 patent's application. This suggests the assignee is continuing to pursue protection for related inventions.

Projected Expiration Date

The term of a U.S. patent is generally 20 years from the filing date of the earliest U.S. non-provisional application to which it claims priority.

1. Earliest Priority Date: The earliest non-provisional filing date in the priority chain is April 30, 2009, from application US 12/433,881.
2. Base Expiration Calculation: Adding 20 years to this date gives a base expiration date of April 30, 2029.
3. Adjustments: As there are no recorded Patent Term Adjustments or Extensions, the base date is the final projected expiration date.

The projected expiration date for US Patent 12,125,070 is April 30, 2029. This aligns with the "Anticipated expiration" date listed in the provided patent information.